Vein adaptation to arterialization in an experimental model

Journal of Vascular Surgery

Volumn 33, Issue 3, 2001, Pages 561-569

  Westerband, Alex ^a   Crouse, Dana ^a   Richter, Lynne C ^a   Aguirre, Maria L ^a   Wixon, Christopher C ^a   James, Donovan C ^a   Mills, Joseph L ^a   Hunter, Glenn C ^a   Heimark, Ronald L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMORAL ARTERY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; VASCULAR SURGERY; VEIN GRAFT;

EID: 0035108560     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.112230     Document Type: Article

References (44)

1. Biologic fate of autogenous vein implants as arterial substitutes: Clinical, angiographic and histopathological observations in femoropopliteal operations for atherosclerosis
2. Experience with in-situ saphenous vein bypasses during 1981 to 1989: Determinant factors of long-term patency
3. Immunocytochemical determination of cell type and proliferation rate in human infrainguinal vein graft stenoses
4. Apoptosis and the regulation of cell numbers in normal and apoptotic tissues: An overview
5. Apoptosis participates in cellularity regulation during rat aortic intimal thickening
6. Topography of cell replication in human vein graft stenoses
7. Intimal growth and neovascularization in human stenotic vein grafts
8. Vein graft intimal hyperplasia: Leucocytes and cytokine gene expression
9. Kinetic-mode, automated double-labeled immunohistochemistry and in situ hybridization in diagnostic pathology
10. Molecular and biological properties of the vascular endothelial growth factor
11. Production of transforming growth factor beta 1 during repair of arterial injury
12. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptor in injured arteries
13. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1-beta-converting enzyme
14. Inhibition of vein graft intimal proliferative lesions in the rat by heparin
15. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model
16. Kinetics of vein graft hyperplasia: Association with tangential stress
17. Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia
18. Histologic fate and endothelial changes of distended and non-distended vein grafts
19. Genetic engineering of vein grafts resistant to atherosclerosis
20. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts
21. Mechanical factors associated with the development of intimal and medial thickening in vein grafts subjected to arterial pressure
22. The functional and morphological consequences of balloon catheter injury in veins
23. Role of ice-like proteases in endothelial cell hypoxic and reperfusion injury
24. Apoptosis in focal cerebral ischemia
25. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
26. Apoptosis after intestinal ischemia-reperfusion injury
27. Apoptosis: A basic biologic phenomenon with wide-ranging implications in tissue kinetics
28. Population dynamics of arterial smooth muscle cells, V: Cell proliferation and cell death during the initial 3 months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimal trauma
29. Kinetics of cellular proliferation after arterial injury, I: Smooth muscle cell growth in the absence of endothelium
30. Apoptosis in vein graft intimal hyperplasia
31. Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model
32. Apoptosis: Molecular mechanisms in programmed cell death
33. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms
34. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications
35. Heparin modulates the composition of extracellular matrix domain surrounding arterial smooth muscle cells
36. Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries
37. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
38. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
39. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
40. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implications for coronary angiogenesis
41. Induction of angiogenesis by smooth muscle cell-derived factor: Possible role in neovascularization in atherosclerotic plaque
42. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
43. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor promote rat aortic angiogenesis in vitro
44. Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells